Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M ... been approved by the FDA for the treatment of type 1 diabetes. Beta Bionics (BBNX) hopes to develop the product ...
Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes researchers have found. That suggests doctors may be able to use data from the devices to help ...